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CONTINUING EDUCATION PROGRAM: EDITORIAL
The  inﬂammatory  breast
In  the  5th  century  BCE,  the  Greek  historian,  Herodotus,
mentions  the  fact  that  Atossa,  Queen  of  ancient  Persia  and
wife  of  Darius,  had  a  breast  tumor.  The  lesion  eventually
became  ulcerated,  since  Atossa  did  not  wish  to  disrobe  or
let  herself  be  examined,  and  her  days  appeared  to  be  num-
After  an  overview  of  the  priority  of  imaging  studies,  a
management  algorithm  is  suggested  and  multidisciplinary
therapeutic  principles  are  discussed  by  Boisserie-Lacroix
et  al.  [8].D
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Francebered.  The  Greek  physician,  Democedes  —  who  was  popular
at  court  for  having  cured  the  king’s  sprained  ankle  —  was
called  in.  Democedes  treated  Queen  Atossa  and  cured  her.
In  exchange,  he  persuaded  the  queen  to  convince  the  king
to  make  war  on  Greece;  he  was  part  of  the  reconnaissance
mission  that  was  sent  there. .  . and  remained  in  Greece,  thus
escaping  from  the  Persian  king  [1].
This  episode  describes  the  ﬁrst  case  of  abscess  reported
in  the  literature,  and  highlights  the  difﬁculty  of  differen-
tiating  inﬂammatory  breast  cancer  from  infectious  disease.
Inﬂammatory  breast  diseases,  whether  benign  or  malignant,
are  rare  in  daily  practice,  but  their  incidence  has  been
increasing  since  1990  [2].
The  clinical  diagnosis  is  essential  for  inﬂammatory  syn-
drome.  Boutet  provides  etiologic  guidance  based  on  whether
or  not  the  woman  is  breast-feeding  [3].
Few  articles  in  the  literature  address  benign  inﬂamma-
tory  disease,  which  is  still  quite  poorly  understood.  Ferron
et  al.  review  the  different  benign  causes,  explaining  and
illustrating  them  [4].
Inﬂammatory  breast  cancer,  which  is  still  called  carcino-
matous  mastitis  (T4d),  is  the  only  true  emergency  situation
in  breast  oncology,  due  to  its  high  metastatic  risk.  Alunni
describes  the  contribution  and  limitations  of  conventional
imaging  [5].
What  is  the  role  of  the  MRI  and  the  PET  scan?  De  Bazelaire
et  al.  specify  the  indications  and  beneﬁt  of  such  studies,
ﬁrstly  for  diagnosis  and  characterization  of  inﬂammatory
symptoms  and  secondly  for  staging  and  monitoring  inﬂam-
matory  carcinoma  treated  with  chemotherapy  [6].
The  diagnostic  strategy  is  different  from  cases  where
there  are  subclinical  images  and  palpable  non-inﬂammatory
masses.  Imaging  of  inﬂammatory  syndromes  is  often  non-
speciﬁc,  and  the  BI-RADS  classiﬁcation  cannot  be  strictly
applied.  It  is  therefore  important  to  know  the  indications  for
percutaneous  biopsy,  the  type  of  biopsy  that  should  be  done,
and  the  radiologic/histologic  correlations,  which  Pages  et  al.
presents  to  us  [7].
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